Arrowhead Pharmaceuticals (ARWR) announced its public offerings, pricing $625M of 0.00% convertible senior notes due in 2032 and 3.1M shares of common stock at $64.50 per share. Instead of common ...

Compass ( COMP) said it priced an $850 million private offering of convertible senior notes due 2031, up $100 million from ...

A favorite trade of 2020 and 2021—buying into a startup shortly before the company is expected to go public, often through ...

FuboTV has confirmed that none of the holders of its convertible senior secured notes due in 2029 elected to tender their ...

You’re a few months into building. You have early users, a half-working product, and one investor asking for your “valuation expectations.” You have no idea what to say. A friend tells you to “just ...

Convertible instruments held steady in Q1 2025, but the terms are shifting in favor of investors. Interest rates on convertible notes rose by 200 to 300 basis points, and discount rates climbed as ...

Realty Income (O) prices $750M 3.5% convertible notes due 2029, with ~20% conversion premium and buyback plans.

This press release includes "forward-looking statements" within the meaning of the within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities ...

New note provides greater repayment flexibility and less dilution with elimination of mandatory amortization payments, increased conversion floor ...

Repurchased $225 million principal amount of convertible notes removing approximately 8.3 million underlying shares as well as approximately $63.8 million of remaining interest Issued 9.45 million ...